Literature DB >> 17487003

Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies.

Gualberto Ruaño1, C Lee Blair, Bruce Bower, Andreas Windemuth, Mohan Kocherla, Yaraliz Aleman, Godfrey Pearlson, John W Goethe, Harold I Schwartz.   

Abstract

A 54-year-old woman presented with severe anxiety, multiple somatic complaints, medication intolerance and adverse drug reactions (ADRs) to numerous prescribed psychotropic medications. Multiple drug metabolizing deficiencies were suspected. Molecular analysis was performed for the CYP2 family of Cytochrome P450 (CYP450) drug metabolism isoenzymes by DNA typing CYP2D6, CYP2C9, and CYP2C19 genes. A multiple deficiency in CYP2 drug metabolism was discovered. The patient was a double carrier of null alleles for CYP2D6, a carrier of a null allele for CYP2C19 and a carrier of a deficient allele for CYP2C9. These alleles were confirmed by Mendelian inheritance in her nuclear family, where her brother had a similar multigene CYP2 deficiency. The patient improved clinically with discontinuation of psychotropic medications, suggesting that much of her symptomatology was drug-induced. DNA typing for multigene CYP2 deficiencies is diagnostically useful in individuals with histories of multiple ADRs, which could be avoided by DNA-guided individualized prescription.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487003

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  3 in total

1.  Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients.

Authors:  Gualberto Ruaño; David Villagra; Bonnie Szarek; Andreas Windemuth; Mohan Kocherla; Krystyna Gorowski; Christopher Berrezueta; Harold I Schwartz; John Goethe
Journal:  Biomark Med       Date:  2011-08       Impact factor: 2.851

2.  Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.

Authors:  David Villagra; John Goethe; Harold I Schwartz; Bonnie Szarek; Mohan Kocherla; Krystyna Gorowski; Andreas Windemuth; Gualberto Ruaño
Journal:  Biomark Med       Date:  2011-08       Impact factor: 2.851

3.  Multiple adverse drug reactions and genetic polymorphism testing: A case report with negative result.

Authors:  Ana Lucía Arellano; Marta Martin-Subero; Mar Monerris; Adrián LLerena; Magí Farré; Eva Montané
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.